Cowen and Company’s Biohaven BHVN Stock Holding History

Cowen and Company’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-78,319	Closed	-$3.35M	–	678
2023 Q4	$3.35M	Buy	+78,319	New	+$2.44M	0.22%	79
2022 Q4	–	Sell	-46,914	Closed	-$289K	–	681
2022 Q3	$289K	Buy	+46,914	New	+$340K	0.03%	149

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cowen and Company's BHVN Position: Q1 2024 in Review

Cowen and Company sold out of Biohaven (BHVN) in Q1 2024, closing a stake of 78,319 shares — an estimated $3.35M sold.

Cowen and Company first reported a position in BHVN in Q3 2022 and held it in 2 quarters. The position peaked at $3.35M in Q4 2023. 243 funds tracked by Wall St. Rank hold BHVN as of Q1 2024.

Cowen and Company reported no remaining Biohaven position as of Q1 2024 after selling out during the quarter.
Cowen and Company sold 78,319 Biohaven shares in Q1 2024, an estimated $3.35M.
Cowen and Company first reported a position in Biohaven in Q3 2022 and held it in 2 quarters.
Cowen and Company's Biohaven position peaked at $3.35M in Q4 2023.
243 funds tracked by Wall St. Rank held Biohaven as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.